Articles in section Licensing

<< Joint Venture

512 articles

Mergers & Acquisitions >>

<< Previous

Pages 1 2 3 4 5 .. 52

Next >>

Takeda Signs US$1.13 B Deal with Hutchmed for Colorectal Cancer Drug Published: 1 Feb-2023
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 2
AbbVie Forms Auto-Immunology Partnership with HotSpot Therapeutics for US$335M Published: 21 Dec-2022
By: Swati Sharan
Abstract Fulltext:
Volume: 2022 Issue: 12
Novartis Signs License Agreement with MorphoSys to Develop and Commercialise Preclinical Inhibitors for Cancer Published: 21 Dec-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 12
Kite Enters into License Agreement with Arcellx for CART-ddBCMA in Multiple Myeloma Published: 16 Dec-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 12
Astellas Turns to AAV-based Gene Therapy with Taysha Gene Therapies Collaboration Deal Published: 9 Nov-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 11
Hookipa Pharma signs US$958 M Deal with Roche to develop HB-700 for KRAS-mutated Cancers Published: 5 Nov-2022
By: Amit Kaushik
Abstract Fulltext:
Volume: 2022 Issue: 11
Jazz Pharmaceuticals Enters into License Agreement with Zymeworks for Zanidatamab Published: 26 Oct-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 10
Bristol Myers Squibb Signs Protein Degradation and Cell Therapy Technology Deals Published: 8 Oct-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 10
Seagen Enters into License Agreement with Lava Therapeutics for LAVA-1223 Published: 7 Oct-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 10
Seagen Signs Collaboration and License Agreement with Zai Lab for Tivdak® Published: 6 Oct-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 10

Login Problems

Please enter your username or email address and we will email you your login details.